 |
|
|
| |
Virological Suppression in People With HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar Across Age Groups Despite Older PWH Having Increased Rates of Comorbidities and Polypharmacy (TANDEM Subgroup Analysis)
|
| |
| |
ID Week Oct 11 2023
Andrew P. Brogan,1 Jihad Slim,2 Gustavo Verdier,3 Gavin Harper,4 Katie Mycock,4 Hannah Wallis,4 Cynthia Donovan1
1ViiV Healthcare, Durham, NC, USA; 2New York Medical College, Valhalla, NY, USA; 3ViiV Healthcare, Montreal, Canada; 4Adelphi Real World, Bollington, UK
|
| |
|
|
|
|
|
